Randomized Trial of Deep Vein Thrombosis Chemoprophylaxis with Bemiparin and Enoxaparin in Patients with Moderate to High Thrombogenic Risk Undergoing Plastic and Reconstructive Surgery Procedures


Por: Revilla-Penaloza, Francisco, Jay Olsoff-Pagovich, Paul, Ramon Ochoa-Gomez, Jose, Castaneda-Gaxiola, Roberto, Ivan Rubio-Gayosso, Angel, Ceballos, Guillermo, Arcadio Molina-Guarneros, Juan

Publicada: 1 jun 2020
Categoría: Surgery

Resumen:
Background Deep vein thrombosis (DVT) is a common complication during postoperative convalescence characterized by hypercoagulability, vascular endothelium damage and blood stasis. It increases noticeably in peri/postoperative phases of surgery procedures. Pulmonary embolism secondary to iliofemoral DVT is a frequent cause of death. Methods Adult patients scheduled for plastic and reconstructive surgery (PRSx) with moderate to high thrombogenic risk were selected. We evaluated the efficacy and safety of bemiparin compared to enoxaparin as chemoprophylaxis for DVT. Following balanced general anesthesia techniques, patients were randomly assigned for subcutaneous enoxaparin 40 IU (Group-E) or bemiparin 3500 IU (Group-B) q24h starting 6 h after procedure conclusion for at least 10 days. All patients were evaluated for DVT through Doppler ultrasound mapping of the lower limbs. Results Seventy-eight patients were evaluated, mostly women (83%), physical status ASA II (59%), ASA III (10%); Caprini's thrombogenic risk score 3-4 (moderate) 58%, 5-6 (high) 29%, > 6 (too high) 13%; demographics, clinical variables and scores were similar between groups. Median drainage time in breast surgery was 4 days in both groups (p = 0.238). In the case of abdominal surgery, median was 14 days in Group-E versus 13 days in Group-B (p = 0.059). No DVT was detected in either group. Conclusions DVT was prevented with bemiparin, without significant bleeding increase nor adverse events; moreover, the cost of bemiparin is lower than enoxaparin. Bemiparin can be considered as alternative drug for DVT chemoprophylaxis in PRSx procedures.

Filiaciones:
Revilla-Penaloza, Francisco:
 Amer British Cowdray Santa Fe Med Ctr, Anesthesiol Serv, 154 Carlos Graef Fernandez Av, Mexico City 053333, DF, Mexico

 Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad, Mexico City 11340, DF, Mexico

Jay Olsoff-Pagovich, Paul:
 ABC Santa Fe Med Ctr, Plast & Reconstruct Surg, 154 Carlos Graef Fernandez Av, Mexico City 053333, DF, Mexico

Ramon Ochoa-Gomez, Jose:
 ABC Santa Fe Med Ctr, Plast & Reconstruct Surg, 154 Carlos Graef Fernandez Av, Mexico City 053333, DF, Mexico

Castaneda-Gaxiola, Roberto:
 ABC Santa Fe Med Ctr, Angiol & Vasc Surg, 154 Carlos Graef Fernandez Av, Mexico City 053333, DF, Mexico

Ivan Rubio-Gayosso, Angel:
 Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad, Mexico City 11340, DF, Mexico

Ceballos, Guillermo:
 Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad, Mexico City 11340, DF, Mexico

Arcadio Molina-Guarneros, Juan:
 Univ Nacl Autonoma Mexico, Fac Med, Pharmacol Dept, Av Univ 3000, Mexico City 04510, DF, Mexico
ISSN: 0364216X
Editorial
Springer-Verlag, ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES, Estados Unidos America
Tipo de documento: Article
Volumen: 44 Número: 3
Páginas: 820-829
WOS Id: 000539127100026
ID de PubMed: 31853609

MÉTRICAS